What is Rapid Micro Biosystems's cumulative cost basis?

Rapid Micro Biosystems (RPID) reported cumulative cost basis of $28.73M in Q1 2026.

How has Rapid Micro Biosystems's cumulative cost basis changed year-over-year?

Rapid Micro Biosystems's cumulative cost basis increased by 3.3% year-over-year, from $27.81M to $28.73M.

What is the long-term trend for Rapid Micro Biosystems's cumulative cost basis?

Over 4 years (2021 to 2025), Rapid Micro Biosystems's cumulative cost basis has grown at a 5.2% compound annual growth rate (CAGR), from $23.09M to $28.27M.

Rapid Micro Biosystems RPID Cumulative Cost Basis

Cumulative Cost Basis at other companies

Bio-Rad LaboratoriesBIO

——

iRadimedIRMD

——

Ginkgo BioworksDNA

——

West Pharmaceutical ServicesWST

——

AbbottABT

——

Other financials

Income statement

See full

Revenue$8.0M+11.1%

Gross profit$371.0K-8.2%

Operating income-$13.9M-18.8%

Net income-$14.3M-26.7%

EPS (diluted)-$0.31-19.2%

Balance sheet

See full

Cash & equivalents$14.1M-26.8%

Total debt$23.8M+301%

Total equity$20.4M-68.9%

Total assets$62.4M-27.0%

Cash flow

See full

Operating cash flow-$15.1M-66.1%

CapEx$394.0K+23.5%

Free cash flow-$15.5M-64.7%

Valuation

See full

Market cap$86.19M-43.8%

Enterprise value$95.86M-31.7%

P/S2.5×-2.6×

Profitability

See full

Operating margin-144.2%-12.7pp

Net margin-145.8%-5.0pp

FCF margin-110.5%-14.9pp

Returns & leverage

See full

Return on equity-116.7%-620pp

Debt / equity1.2×+1.1×

Current ratio2.6×-2.0×

Where this comes from

Reported directly by Rapid Micro Biosystems in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentGross.

The official record: Rapid Micro Biosystems’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rapid Micro Biosystems's cumulative cost basis.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Rapid Micro Biosystems's cumulative cost basis?: Rapid Micro Biosystems (RPID) reported cumulative cost basis of $28.73M in Q1 2026.
How has Rapid Micro Biosystems's cumulative cost basis changed year-over-year?: Rapid Micro Biosystems's cumulative cost basis increased by 3.3% year-over-year, from $27.81M to $28.73M.
What is the long-term trend for Rapid Micro Biosystems's cumulative cost basis?: Over 4 years (2021 to 2025), Rapid Micro Biosystems's cumulative cost basis has grown at a 5.2% compound annual growth rate (CAGR), from $23.09M to $28.27M.